The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is soliciting applications from institutions/organizations to establish or maintain a Pharmacokinetics Resource Laboratory (PK Laboratory) to support the Experimental Therapeutics Clinical Trials Network (ETCTN). The PK Laboratory will organize biospecimen collections and provide analyses of pharmacokinetic endpoints, drug-drug interactions, and other related studies. The goal of the ETCTN PK Laboratory is to advance the clinical development of NCI Investigational New Drug (IND) agents by providing a comprehensive understanding of pharmacokinetic behavior. Key responsibilities include: • Organizing biospecimen collections • Providing analyses of pharmacokinetic endpoints • Engaging physicians, clinical pharmacologists, nurses, and scientists with expertise in pharmacokinetic studies • Collaborating with the ETCTN Lead Academic Organizations and their participating sites